Actus Mer/Sea News: Isolation, identification, molecular docking analysis, and cytoprotection of seven novel angiotensin I-converting enzyme inhibitory peptides from miiuy croaker byproducts-swim bladders - @FrontMarineSci http://dlvr.it/SVWQb8
Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (J.E. Lange) Imbach identified by LC-MS/MS.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2022 – Sep 2025Where it's discussed
-
YouTube2 videos
-
Bluesky1 posts
AI synopsis
What people are saying
The overall sentiment indicates cautious optimism, with discussions noting the discovery and stability of peptides like AHEPVK and RIGLF, but lacking extensive debate or detailed reactions. The tone remains neutral, using technical terms to describe the methodology and possible health benefits, which signifies interest but limited deep engagement at this stage.
Some discussions express positive recognition of the research's potential, indicating general agreement on its relevance.
The social discussions show mild curiosity, with mentions of specific peptides and methods but lacking enthusiastic language.
Conversations are somewhat superficial, referencing techniques like molecular docking without in-depth analysis.
The posts suggest that the research could contribute to dietary or medicinal advancements, implying moderate potential impact.
Abstract in brief
- Researchers identified six potent ACE-inhibitory peptides from edible mushroom Agaricus bisporus, with AHEPVK, RIGLF, and PSSNK showing the strongest activity.
- These peptides remain effective after gastrointestinal digestion and act as both competitive and noncompetitive inhibitors of ACE, suggesting they could help manage hypertension.
- Mushrooms like Agaricus bisporus are promising as dietary sources of natural ACE inhibitors, offering a safe and readily available option for antihypertensive supplement development.]
Top posts
Most liked on X and BlueskyAll mentions
Antiviral Potential of Artemisia annua Extracts Against SARS-CoV-2
Artemisia annua L. extracts have demonstrated the ability to inhibit the replication of SARS-CoV-2 and its variants. This video explores the antiviral activity of different cultivars and highlights important findings…
Potential of Artemisia annua Extracts Against SARS-CoV-2
Artemisia annua L. extracts have demonstrated the ability to inhibit the replication of SARS-CoV-2 and its variants, suggesting potential as a treatment option. The study tested extracts from several cultivars…
Actus Mer/Sea News: Isolation, identification, molecular docking analysis, and cytoprotection of seven novel angiotensin I-converting enzyme inhibitory peptides from miiuy croaker byproducts-swim bladders - @FrontMarineSci http://dlvr.it/SVWQb8